A systematic review of neuroimaging studies of clozapine-resistant schizophrenia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
A systematic review of neuroimaging studies of clozapine-resistant schizophrenia ; volume:9 ; number:1 ; day:26 ; month:9 ; year:2023 ; pages:1-16 ; date:12.2023
Schizophrenia ; 9, Heft 1 (26.9.2023), 1-16, 12.2023
- Urheber
-
Pang, Tiffanie Sze Wing
Chun, Johnny Siu Wah
Wong, Ting Yat
Chu, Sin Ting
Ma, Chak Fai
Honer, William G.
Chan, Sherry Kit Wa
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41537-023-00392-7
- URN
-
urn:nbn:de:101:1-2024020512280203515463
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pang, Tiffanie Sze Wing
- Chun, Johnny Siu Wah
- Wong, Ting Yat
- Chu, Sin Ting
- Ma, Chak Fai
- Honer, William G.
- Chan, Sherry Kit Wa
- SpringerLink (Online service)
Ähnliche Objekte (12)
An international research agenda for clozapine-resistant schizophrenia
Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study
Long-term outcomes of delayed clozapine initiation in treatment-resistant schizophrenia: a multicenter retrospective cohort study
Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia
Iranian psychiatrists’ attitude towards clozapine use for patients with treatment-resistant schizophrenia: a nationwide survey
Clozapine-associated Development of Second-onset Obsessive Compulsive Symptoms in Schizophrenia: Impact of Clozapine Serum Levels and Fluvoxamine Add-on
Multiple serum anti-glutamate receptor antibody levels in clozapine-treated/naïve patients with treatment-resistant schizophrenia
Response to clozapine in treatment resistant schizophrenia is related to alterations in regional cerebral blood flow
A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia
Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia
Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine
Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts
An international research agenda for clozapine-resistant schizophrenia
Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study
Long-term outcomes of delayed clozapine initiation in treatment-resistant schizophrenia: a multicenter retrospective cohort study
Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia
Iranian psychiatrists’ attitude towards clozapine use for patients with treatment-resistant schizophrenia: a nationwide survey
Clozapine-associated Development of Second-onset Obsessive Compulsive Symptoms in Schizophrenia: Impact of Clozapine Serum Levels and Fluvoxamine Add-on
Multiple serum anti-glutamate receptor antibody levels in clozapine-treated/naïve patients with treatment-resistant schizophrenia
Response to clozapine in treatment resistant schizophrenia is related to alterations in regional cerebral blood flow
A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia
Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia
Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine
Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts
An international research agenda for clozapine-resistant schizophrenia
Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study
Long-term outcomes of delayed clozapine initiation in treatment-resistant schizophrenia: a multicenter retrospective cohort study
Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia
Iranian psychiatrists’ attitude towards clozapine use for patients with treatment-resistant schizophrenia: a nationwide survey
Clozapine-associated Development of Second-onset Obsessive Compulsive Symptoms in Schizophrenia: Impact of Clozapine Serum Levels and Fluvoxamine Add-on
Multiple serum anti-glutamate receptor antibody levels in clozapine-treated/naïve patients with treatment-resistant schizophrenia
Response to clozapine in treatment resistant schizophrenia is related to alterations in regional cerebral blood flow
A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia
Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia
Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine